White matter alterations within the brain are associated with cognitive impairment among individuals with and without major ...

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

P rogress in addressing mental health is notoriously slow and mostly incremental. Breakthrough treatments tend to be rare, ...

The following is a summary of “Service coverage for major depressive disorder: estimated rates of minimally adequate ...

The most-read articles addressing mental health in 2024 spanned therapeutic advancements, research discoveries, and insight ...

Racial and ethnic disparities are found among Asian individuals as they experience the highest lifetime incidence of alopecia ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

PTSD is a serious mental health condition marked by changes in mood, intrusive memories, avoidant behavior, and a heightened ...

A thin wire connects the device to the left vagus nerve in the neck – a major nerve that serves as a communication highway ...

Chardan initiated coverage of Mind Medicine (MNMD) with a Buy rating and $20 price target The firm cites the potential of the company’s lead ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...